Research Topics
Genomes and Genes | E C HollandSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesisAlan H Shih
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer Res 64:4783-9. 2004..Our data show that PDGFR signaling quantitatively regulates tumor grade and is required to sustain high-grade oligodendrogliomas...
The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formatsChengkai Dai
Department of Surgery (Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Neoplasia 7:397-406. 2005..The ability of signaling activity to convert tumor cells from one lineage to another presents a mechanism for the development of tumors apparently comprised of cells from multiple lineages...
Applications of mouse glioma models in preclinical trialsXiaoyi Hu
Department of Cell Biology and Genetics, New York, NY 10021, USA
Mutat Res 576:54-65. 2005....
Genetically engineered models have advantages over xenografts for preclinical studiesOren J Becher
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer Res 66:3355-8, discussion 3358-9. 2006..These new technologies will hopefully support the use of GEMs in preclinical trials and help determine if trials in GEMs are more predicative than xenografts of human responses...
Modeling and preclinical trials for gliomasMaria Salpietro
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Clin Neurosurg 52:104-11. 2005
Progenitor cells and glioma formationE C Holland
Department of Cell Biology, Memorial Sloan Kettering Cancer Center, RRL, Rm 917B, 1275 York Ave, New York, NY 10021, USA
Curr Opin Neurol 14:683-8. 2001..These data imply that small molecules that promote differentiation may be a rational component of glioma therapy in combination with other drugs aimed at specific molecular signaling targets...
Mouse models of human cancer as tools in drug developmentEric C Holland
Memorial Sloan Kettering Cancer Center, Departments of Surgery Neurosurgery, Neurology, and Cell Biology and Genetics, 1275 York Avenue, New York, NY 10021, USA
Cancer Cell 6:197-8. 2004..They demonstrate that targeting signaling components downstream of tumor initiating mutations can be an effective therapeutic strategy for solid tumors...
Signaling control of mRNA translation in cancer pathogenesisEric C Holland
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Oncogene 23:3138-44. 2004..Although many studies have correlated deregulation of protein biosynthesis with cancer, it remains to be established whether this process is necessary and/or sufficient for neoplastic transformation and metastasis...
Animal models of cell cycle dysregulation and the pathogenesis of gliomasE C Holland
Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Neurooncol 51:265-76. 2001..The results of these mouse model experiments imply a potentially complex role for cell cycle arrest disruption in human gliomagenesis...
Brain tumor animal models: importance and progressE C Holland
Department of Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Curr Opin Oncol 13:143-7. 2001..In addition, these mouse-modeling experiments may identify essential targets for therapy and provide test animals for preclinical trials of mechanistically designed therapeutics...
Gliomagenesis: genetic alterations and mouse modelsE C Holland
Departments of Neurosurgery, Neurology and Cell Biology, Memorial Sloan Kettering Cancer Center, 1, 275 York Avenue, New York, New York 10021, USA
Nat Rev Genet 2:120-9. 2001..Recent modelling experiments in mice are helping to delineate the molecular aetiology of this disease and are providing systems to identify and test novel and rational therapeutic strategies...
Regulation of translation and cancerEric C Holland
Memorial Sloan Kettering Cancer Center, Department of Surgery Neurosurgery, New York, New York 10021, USA
Cell Cycle 3:452-5. 2004..It is not known whether this effect is sufficient to induce cancer from cells with an initial non-neoplastic gene expression profile...
Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivoE C Holland
Department of Neurosurgery, Graduate Program in Genes and Development, M D Anderson Cancer Center, Houston, Texas 77030, USA
Am J Pathol 157:1031-7. 2000..We conclude that GFAP- expressing astrocytes, with appropriate signaling abnormalities, can serve as the cell of origin for oligodendrogliomas, astrocytomas, or mixed gliomas...
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivoC Dai
Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 15:1913-25. 2001..Loss of Ink4a-Arf is not required for PDGF-induced glioma formation but promotes tumor progression toward a more malignant phenotype...
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastomaXiaoyi Hu
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Neoplasia 7:356-68. 2005....
Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomesVinagolu K Rajasekhar
Department of Surgery Neurosurgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Mol Cell 12:889-901. 2003..These data support a model whereby Ras and Akt signaling primarily lead to cellular transformation by altering the transcriptome and producing a radical shift in the composition of mRNAs associated with actively translating polysomes...
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated AktLene Uhrbom
Department of Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 62:5551-8. 2002..Our data strongly supports the view that one role of loss of Ink4a-Arf in gliomagenesis could be to sensitize astrocytes to transformation through dedifferentiation in response to the appropriate oncogenic stimuli...
Glioma modelsC Dai
Departments of Cell Biology, Neurology, and Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Biochim Biophys Acta 1551:M19-27. 2001....
Akt phosphorylation of La regulates specific mRNA translation in glial progenitorsF Brenet
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Oncogene 28:128-39. 2009..Therefore, La appears to be an important contributor to Akt-mediated translational regulation of these transcripts in murine glial cells...
Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivoHiroyuki Momota
Department of Cancer Biology and Genetics and Surgery (Neurosurgery) and Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 65:7429-35. 2005..01). These results indicate that perifosine is an effective drug in gliomas in which Akt and Ras-Erk 1/2 pathways are frequently activated, and may be a new candidate for glioma treatment in the clinic...
Mouse models of brain tumors and their applications in preclinical trialsElena I Fomchenko
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 12:5288-97. 2006..These mouse models, in turn, increase our understanding of brain tumor initiation, formation, progression, and metastasis, providing an experimental system to discover novel therapeutic targets and test various therapeutic agents...
A mouse model for glioma: biology, pathology, and therapeutic opportunitiesE C Holland
M D Anderson Cancer Center, Department of Neurosurgery, Houston, Texas 77030, USA
Toxicol Pathol 28:171-7. 2000..These genetically defined animal models for gliomas will allow for the testing of therapies that are targeted specifically at the gene products involved in the pathogenesis of gliomas...
Modeling gliomagenesis with somatic cell gene transfer using retroviral vectorsL Uhrbom
Department of Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Neurooncol 53:297-305. 2001..The current models provide tumors, which are genetically and histologically similar to their human counterparts, making them attractive to use in drug discovery for treatment of gliomas...
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human gliomaMeena K Tanwar
Department of Surgery (Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 62:4364-8. 2002..YKL-40 serum levels were substantially elevated in many of the GBM patients. Statistical analysis of these data indicates that in patients with glioma, serum YKL-40 levels correlate with tumor grade and potentially tumor burden in GBM...
c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in miceH Momota
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Oncogene 27:4392-401. 2008..These data provide insights into the biology and classification of human PNETs and suggest that multiple tumor types or variants can be generated from a fixed set of genetic abnormalities...
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor geneVioletta Barbashina
Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Clin Cancer Res 11:1119-28. 2005..To better define the histologic correlates of different patterns of 1p and 19q loss, we evaluated 1p/19q status in a large group of gliomas. This also allowed us to define a very small minimal deleted region (MDR) on 1p36...
Genetic modeling of glioma formation in miceMartin Begemann
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Brain Pathol 12:117-32. 2002....
Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomasOren J Becher
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer Res 68:2241-9. 2008..Lastly, we observe that SHH is similarly expressed in human gliomas and note that an intact tumor microenvironment or neurosphere conditions in vitro are required for Gli activity...
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomasAdilia Hormigo
Clinical Laboratories, Neurosurgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Clin Cancer Res 12:5698-704. 2006..We obtained prospective longitudinal serum samples from patients with gliomas to determine whether YKL-40 or MMP-9 could be used as serum markers...
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 11:7841-50. 2005....
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomasMichelle S Bradbury
Department of Radiology, Sloan Kettering Institute for Cancer Research, New York, New York 10021, USA
J Nucl Med 49:422-9. 2008..Our goal was to develop a robust and reproducible method of kinetic analysis for the quantitative evaluation of tumor proliferation...
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivoDolores Hambardzumyan
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 22:436-48. 2008..These cellular characteristics are similar to human medulloblastomas. Finally, inhibition of Akt signaling sensitizes cells in the perivascular region to radiation-induced apoptosis...
Incorporating molecular tools into clinical trials and treatment for gliomas?Andrew B Lassman
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Curr Opin Neurol 20:708-11. 2007..Knowledge of the molecular biology of gliomas may improve therapy. This review highlights several recent studies on this topic...
Genetically engineered mouse models of brain cancer and the promise of preclinical testingJason T Huse
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Brain Pathol 19:132-43. 2009..Examples showcasing the use of GEMMs in the testing of molecularly targeted therapeutics are given, and relevant topics, such as stem cell biology, in vivo imaging technology and radiotherapy, are also addressed...
Early detection and prognosis of ovarian cancer using serum YKL-40Jakob Dupont
Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Howard 905, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 22:3330-9. 2004..YKL-40 is a secreted glycoprotein (chitinase family). We compared YKL-40 with two ovarian cancer serum markers, CA125 and CA15-3, for the detection of early-stage ovarian cancer...
Notch signaling enhances nestin expression in gliomasAlan H Shih
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Neoplasia 8:1072-82. 2006..However, activation of Notch alone is unable to induce this cellular expansion. These data suggest that Notch may have a contributing role in the stem-like character of glioma cells...
MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trialsJason A Koutcher
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Neoplasia 4:480-5. 2002..In contrast, low-grade murine oligodendrogliomas do not reveal contrast enhancement, similar to human tumors. MRI can be used to identify mice with brain neoplasms as inclusion criteria in preclinical trials...
Postgenomic global analysis of translational control induced by oncogenic signalingVinagolu K Rajasekhar
Department of Surgery Neurosurgery, Neurology, Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Oncogene 23:3248-64. 2004..To what degree this translational control is either necessary or sufficient for tumor formation or maintenance remains to be determined...
Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localizationBobby Bhatia
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 69:7224-34. 2009....
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in miceE C Holland
Department of Neurosurgery, MD Anderson Cancer Center, Houston, Texas, USA
Nat Genet 25:55-7. 2000..11), and we show here that Akt activity is increased in most of these tumours, implying that combined activation of these two pathways accurately models the biology of this disease...
In vivo multiple-mouse imaging at 1.5 TS Xu
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Magn Reson Med 49:551-7. 2003..The multiple mouse coil is simple in construction and may be implemented without any significant modification to the hardware or software on a clinical scanner...
EGFR signaling is differentially activated in patient-derived glioblastoma stem cellsBrian M Howard
Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York, New York, 10065, USA
J Exp Ther Oncol 8:247-60. 2010..Sphere formation by EGFR-/ PTEN- GSCs was independent of EGF stimulation, but dependant on B27 growth supplement. Our data suggest that EGFR+/PTEN+ GSCs are susceptible to anti-EGFR therapy in vitro...
New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humansAnne Marie Bleau
Department of Neurological Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
Neurosurg Focus 24:E28. 2008..Therefore, the purpose of this study was to develop a new method to better understand the proteomic profile of the entire population of cells within a sphere...
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomasTatsuya Ozawa
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Genes Dev 24:2205-18. 2010..These results suggest the possibility that these PDGFRA mutants behave as oncogenes in this subset of gliomas, and that the prevalence of such rearrangements may have been considerably underestimated...
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cellsAnne Marie Bleau
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell Stem Cell 4:226-35. 2009..This Akt-induced ABCG2 activation results from its transport to the plasma membrane. Temozolomide, the standard treatment of gliomas, although not an ABCG2 substrate, increases the SP in glioma cells, especially in cells missing PTEN...
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignanciesSelvaraju Veeriah
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Nat Genet 42:77-82. 2010..These data strongly point to PARK2 as a tumor suppressor on 6q25.2-q27. Thus, PARK2, a gene that causes neuronal dysfunction when mutated in the germline, may instead contribute to oncogenesis when altered in non-neuronal somatic cells...
p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3Rebecca M Wolf
Department of Cell Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 17:476-87. 2003..This evidence strongly suggests that p190 regulates critical components of PDGF oncogenesis and can act as a tumor suppressor in PDGF-induced gliomas by down-regulating Rho activity...
Constitutive activation of Raf-1 induces glioma formation in miceYelena Lyustikman
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Neoplasia 10:501-10. 2008..Our study suggests that the oncogenic effect of KRas in glioma formation may be transduced at least in part through Raf signaling and that therapeutic targeting of this pathway may be beneficial in glioma treatment...
Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in miceGanesh Rao
Department of Neurosurgery, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, UT 84132-2303, USA
Oncogene 23:6156-62. 2004..These results indicate that combined activation of the Shh/Ptc and IGF signaling pathways is an important mechanism in MB pathogenesis...
c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in miceGanesh Rao
Department of Neurosurgery, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, UT 84132, USA
Neoplasia 5:198-204. 2003..We conclude that nestin-expressing neural progenitors, present in the cerebellum at birth, can act as the cells-of-origin for medulloblastoma, and that c-Myc cooperates with Shh to enhance tumorigenicity...
Trapping the mouse genome to hunt human alterationsAnne-Marie Bleau
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Proc Natl Acad Sci U S A 104:7737-8. 2007
Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitmentElena I Fomchenko
Department of Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Neurosurg Clin N Am 18:39-58, viii. 2007..In this view, glioma formation involves recruitment of cells from the adjacent brain and possibly other sites...
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastomaJason T Huse
Departments of Pathology, 408 East 69th Street Z1304, New York, NY 10065, USA
Nat Rev Cancer 10:319-31. 2010..This Review summarizes these developments in the context of the evolving notion of molecular pathology and discusses the implications that this work has on the design of new treatment regimens...
Cancer stem cells and survival pathwaysDolores Hambardzumyan
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cell Cycle 7:1371-8. 2008..1) It remains to be determined whether this mechanism of tumor resistance applies to the more complex stem-cell niche and tumor bulk of gliomas...
Glioma formation, cancer stem cells, and akt signalingDolores Hambardzumyan
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Stem Cell Rev 4:203-10. 2008..In human gliomas, these two theories are not mutually exclusive. In this review we will summarize both theories, and highlight outstanding issues that remain to be resolved...
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivoJason T Huse
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 23:1327-37. 2009..Our results document a new epigenetic mechanism for PTEN regulation in glioma and further highlight dysregulation of Akt signaling as crucial to the development of these tumors...
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cellsAngel Ayuso-Sacido
Department of Neurosurgery, Neurosurgical Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Weill Cornell Medical College of Cornell University, New York, NY, USA
J Neurooncol 97:323-37. 2010..Understanding the regulatory mechanisms of NSCs may lend insight into deregulated mechanisms of GBM TSC invasion, proliferation, survival and resistance to current treatment modalities...
Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometryJosep Villanueva
Protein Center, Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Anal Chem 76:1560-70. 2004..This, in turn, served to create a learning algorithm that correctly predicted 96.4% of the samples as either normal or diseased...
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activationA Fernandez-L
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Oncogene 31:1923-37. 2012..Our results establish a central role for YAP in counteracting radiation-based therapies and driving genomic instability, and indicate the YAP/IGF2/Akt axis as a therapeutic target in medulloblastoma...
Surgical resection of intrinsic insular tumors: complication avoidanceF F Lang
Department of Neurosurgery, The University of Texas M D Anderson Cancer Center, Houston, USA
J Neurosurg 95:638-50. 2001....
Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem gliomaOren J Becher
Departments of Cancer Biology and Genetics, Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 70:2548-57. 2010..92). Perifosine + 10 Gy did not result in a significantly increased survival relative to 10 Gy alone (P = 0.23). This PDGF-induced BSG model can serve as a preclinical tool for the testing of novel agents...
Organ donors with malignant gliomas: an updateFederic P Collignon
Department of Surgery, Division of Neurosurgery, Memorial Sloane Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
Am J Transplant 4:15-21. 2004..We will then present recent knowledge regarding basic glioma biology that speaks to their metastatic potential and suggest rational strategies for the post-transplant management of recipients of organs from donors with glioma...
The perivascular niche microenvironment in brain tumor progressionNikki Charles
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cell Cycle 9:3012-21. 2010..Characterization of the signaling pathways and intercellular communication between resident cell types in the microvascular niche of brain tumors is critical to the identification of potential BTSC-specific targets for therapy...
The ABCG2 resistance network of glioblastomaAnne Marie Bleau
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cell Cycle 8:2936-44. 2009....
Radiation resistance and stem-like cells in brain tumorsDolores Hambardzumyan
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Cell 10:454-6. 2006..The data raise many questions about the details of radiobiology of stem-like cells in their native environment within tumors in vivo. These answers may lead to better optimization of radiation treatments and schedules for these patients...
MYC expression promotes the proliferation of neural progenitor cells in culture and in vivoDan Fults
Department of Neurosurgery, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City 84132 2303, USA
Neoplasia 4:32-9. 2002..Although overexpression of MYC is not sufficient to cause intraparenchymal tumors, it may facilitate PNET formation by sustaining the growth of undifferentiated progenitor cells...
Bioluminescence technology for imaging cell proliferationHiroyuki Momota
Department of Cancer Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Curr Opin Biotechnol 16:681-6. 2005..These technologies support more detailed preclinical trials and could enable other biological pathways to be monitored in living cells...
Stem cells and brain cancerElena I Fomchenko
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Exp Cell Res 306:323-9. 2005..It is likely that a complete description of the role of stem cells in brain tumors will be more complex than our current models...
Astrocyte differentiation states and glioma formationChengkai Dai
Department of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer J 9:72-81. 2003..In this review, we discuss new insights into the parallels between glial differentiation and glioma formation as well as the potential application of differentiation-inducing therapy...
Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cellsNikki Charles
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell Stem Cell 6:141-52. 2010..This mechanism is conserved in human PDGFR amplified gliomas. The NO/cGMP/PKG pathway's promotion of stem cell-like character in the tumor PVN may identify therapeutic targets for this subset of gliomas...
Platelet-derived growth factor (PDGF) and glial tumorigenesisAlan H Shih
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Lett 232:139-47. 2006..The development of small molecules that inhibit the PDGF receptor and various subsequent signaling components promises to introduce new approaches to the treatment of gliomas...
Origins of brain tumors--a disease of stem cells?Elena I Fomchenko
Department of Cancer Biology and Genetics, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA
Nat Clin Pract Neurol 2:288-9. 2006
Developmental neurobiology and the origin of brain tumorsAlan H Shih
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Neurooncol 70:125-36. 2004..By appreciating the inter-relationship between tumor formation and development, we maybe able to design new therapeutics targeting tumors for new modes of treatment...
Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesisLene Uhrbom
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala, Sweden
Cancer Res 65:2065-9. 2005..Thus, Ink4a and Arf have independent and differential tumor suppressor functions in vivo in the glial cell compartment...
Using mice to decipher the molecular genetics of brain tumorsGöran Hesselager
Departments of Neurosciences Division of Neurosurgery and Genetics and Pathology, University Hospital, Uppsala, Sweden
Neurosurgery 53:685-94; discussion 695. 2003..We present here a review of current models, with a focus on gliomas and medulloblastomas...
Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptorSarah V Bradley
Department of Internal Medicine, University of Michigan Medical School, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Cancer Res 67:3609-15. 2007..Further investigation of HIP1 function in brain cancer biology and validation of its use as a prognostic or predictive brain tumor marker are now warranted...
Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of gliomaPatrick McConville
MIR Preclinical Services, Inc, Ann Arbor, Michigan, USA
Clin Cancer Res 13:2897-904. 2007..The nestin tv-a (Ntv-a) genetically engineered mouse spontaneously develops glioma when infected with ALV-A expressing platelet-derived growth factor, resulting in autocrine platelet-derived growth factor signaling...
Insulin-like growth factor binding protein 2 promotes glioma development and progressionSarah M Dunlap
Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Proc Natl Acad Sci U S A 104:11736-41. 2007..Thus, this study provides definitive evidence that IGFBP2 plays a key role in activation of the Akt pathway and collaborates with K-Ras or PDGFB in the development and progression of two major types of glioma...
Cooperative translational control of gene expression by Ras and Akt in cancerAndrew T Parsa
Department of Neurological Surgery, University of California San Francisco, CA 94143, USA
Trends Mol Med 10:607-13. 2004..The downstream components of these pathways have provided therapeutic targets that are currently being tested in clinical trials...
Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma modelLene Uhrbom
Uppsala University, Department of Genetics and Pathology, Rudbeck Laboratory, SE-75185 Uppsala, Sweden
Nat Med 10:1257-60. 2004..In these platelet-derived growth factor (PDGF)-driven oligodendrogliomas, G1 cell-cycle arrest is generated by blockade of either the PDGF receptor or mTOR using small-molecule inhibitors...
Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transferMaria P De Miguel
Kimmel Cancer Center, Thomas Jefferson University, Bluemle Life Sciences Building, Room 706, 233 South 10th Street, Philadelphia, PA 19107, USA
Proc Natl Acad Sci U S A 99:10458-63. 2002..Such technology for manipulating gene expression in PGCs will allow many of the molecular mechanisms regulating germ cell growth, behavior, and differentiation to be comprehensively analyzed...
Molecular imaging of Akt kinase activityLimin Zhang
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA
Nat Med 13:1114-9. 2007..The results provide unique insights into the pharmacokinetics and pharmacodynamics of agents that modulate Akt activity, revealing the usefulness of this reporter for rapid dose and schedule optimization in the drug development process...
Differential exoprotease activities confer tumor-specific serum peptidome patternsJosep Villanueva
Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Clin Invest 116:271-84. 2006..Our findings also have important implications for future peptide biomarker discovery efforts...
Research Grants
- Pre-Clinical Trials of GEM Models for GliomasEric Holland; Fiscal Year: 2007..abstract_text> ..
- Requirements for generation and maintenance of gliomasEric Holland; Fiscal Year: 2007..In this grant we will address these questions using the RCAS/tv-a mouse modeling system for Ras + Akt-induced gliomas. ..
- Modeling the effects of INK4 alpha ARF loss on gliomasEric Holland; Fiscal Year: 2003....
- The Role of Signaling Pathways in Brain Tumors in MiceEric C Holland; Fiscal Year: 2010..This grant proposes to use mouse models medulloblastomas and gliomas to understand the biology of stem cells in these tumors and their response to therapy. ..
